HUTCHMED (China) (HCM) Change in Acquisitions & Divestments (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Change in Acquisitions & Divestments came in at $50.0 million in Q2 2021, down 73.95% year-on-year from $191.8 million in Q2 2020, and down 74.97% on a QoQ basis from $199.5 million in Q1 2021.
HUTCHMED (China) (HCM) Change in Acquisitions & Divestments (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $50.0 million in Q2 2021.
- On a quarterly basis, Change in Acquisitions & Divestments fell 73.95% year-over-year to $50.0 million in Q2 2021; TTM through Jun 2021 was $537.3 million, a 8.6% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 20.29% from the prior year.
- Change in Acquisitions & Divestments for Q2 2021 stood at $50.0 million, down from $199.5 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for HCM reached as high as $273.0 million in Q1 2018 and fell as low as $50.0 million in Q2 2021.
- Historically, Change in Acquisitions & Divestments has averaged $174.7 million across 4 years, with a median of $195.7 million in 2020.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 107.84% in 2021 and fell as far as 73.95% in 2021.
- Year by year, Change in Acquisitions & Divestments stood at $202.4 million in 2018, then tumbled by 70.4% to $59.9 million in 2019, then surged by 220.0% to $191.8 million in 2020, then tumbled by 73.95% to $50.0 million in 2021.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $50.0 million in Q2 2021, $199.5 million in Q1 2021, and $191.8 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 9.57 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 49.95 Mn |
| Jun 30, 2021 | 49.95 Mn |
| Mar 31, 2021 | 199.55 Mn |
| Mar 31, 2021 | 199.55 Mn |
| Jun 30, 2020 | 191.76 Mn |
| Jun 30, 2020 | 191.76 Mn |
| Mar 31, 2020 | 96.01 Mn |
| Mar 31, 2020 | 96.01 Mn |
| Dec 31, 2019 | 59.93 Mn |
| Dec 31, 2019 | 59.93 Mn |
| Sep 30, 2019 | 147.03 Mn |
| Sep 30, 2019 | 147.03 Mn |
| Jun 30, 2019 | 180.17 Mn |
| Jun 30, 2019 | 180.17 Mn |
| Mar 31, 2019 | 209.92 Mn |
| Mar 31, 2019 | 209.92 Mn |
| Dec 31, 2018 | 202.44 Mn |
| Dec 31, 2018 | 202.44 Mn |
| Sep 30, 2018 | 242.19 Mn |
| Sep 30, 2018 | 242.19 Mn |